Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 401–500 of 2,099
Li, Z.-Y., Na, H., Gong, P., Pu, J., & Liu, P. (2010) · Molecular BioSystems · doi:10.1039/c0mb00230e · Cited by 52
McLaughlin, C. M., Harnedy-Rothwell, P. A., Lafferty, R. A., Sharkey, S., Parthsarathy, V., Allsopp, P. J., McSorley, E. M., FitzGerald, R. J., & O’Harte, F. P. M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02583-3 · Cited by 45
Hormones, Metabolism and the Benefits of Exercise
(2017) · Research and Perspectives in Endocrine Interactions · doi:10.1007/978-3-319-72790-5 · Cited by 44
Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer
Shao, G., Qian, Y., Lu, L., Liu, Y., Wu, T., Ji, G., & Xu, H. (2022) · Journal of Cancer · doi:10.7150/jca.71619 · Cited by 58
“Skeletal muscle is the site of the greatest glucose handling in humans [66,67].”
BackgroundMeasuring GLUT4 translocation in mature muscle fibers
Lauritzen, H. P. M. M., & Schertzer, J. D. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00066.2010 · Cited by 44
Dahlmans, D., Houzelle, A., Schrauwen, P., & Hoeks, J. (2016) · Clinical Science · doi:10.1042/cs20150780 · Cited by 44
“Since skeletal muscle accounts for the majority of post-prandial glucose uptake, this tissue is considered as a major player in obesity-related metabolic disturbances [3].”
BackgroundZhang, S., Wu, T., Chen, M., Guo, Z., Yang, Z., Zuo, Z., & Wang, C. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b01597 · Cited by 44
Chursa, U., Nuñez‐Durán, E., Cansby, E., Amrutkar, M., Sütt, S., Ståhlman, M., Olsson, B., Borén, J., Johansson, M. E., Bäckhed, F., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4171-5 · Cited by 50
“Discussion Insulin resistance in skeletal muscle is a major and early feature in the pathogenesis of type 2 diabetes [37].”
BackgroundYu, N., Fang, X., Zhao, D., Mu, Q., Zuo, J., Ma, Y., Zhang, Y., Mo, F., Zhang, D., Jiang, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168980 · Cited by 49
Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes
Väremo, L., Henriksen, T. I., Scheele, C., Broholm, C., Pedersen, M., Uhlén, M., Pedersen, B. K., & Nielsen, J. (2017) · Genome Medicine · doi:10.1186/s13073-017-0432-2 · Cited by 44
“sistance in skeletal muscle is considered to be one of the early key defects in the development of T2D [8].”
BackgroundBakar, M. H. A., & Tan, J. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.021 · Cited by 48
Son, M., & Wu, J. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1753-7 · Cited by 48
Xia, X., Xu, J., Wang, X., Wang, H., Lin, Z., Shao, K., Fang, L., Zhang, C., & Zhao, Y. (2020) · Food & Function · doi:10.1039/d0fo00395f · Cited by 53
Yoon, S., Ahn, D., Hwang, J. Y., Kang, M. J., & Chung, S. J. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104532 · Cited by 54
Naowaboot, J., Somparn, N., Saentaweesuk, S., & Pannangpetch, P. (2015) · Phytotherapy Research · doi:10.1002/ptr.5392 · Cited by 47
Exposure to perfluorooctane sulfonate reduced cell viability and insulin release capacity of β cells
Qin, W., Ren, X., Zhao, L., & Guo, L. (2021) · Journal of Environmental Sciences · doi:10.1016/j.jes.2021.07.004 · Cited by 48
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
Rabbani, N., & Thornalley, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052453 · Cited by 49
“Correction of insulin resistance by tRES-HESP suggests this supplement may be appropriate for the prevention and early-stage reversal of T2DM [57,58].”
BackgroundDysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications
Sehrawat, A., Mishra, J., Mastana, S. S., Navik, U., Bhatti, G. K., Reddy, P. H., & Bhatti, J. S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166666 · Cited by 50
Lean nonalcoholic fatty liver disease and sarcopenia
Chen, M., Cao, Y. Y., Ji, G., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217249 · Cited by 54
“TNF-a also induces lipid accumulation in the liver by activating DNL (71).”
BackgroundWhytock, K. L., & Goodpaster, B. H. (2025) · Circulation Research · doi:10.1161/circresaha.125.325532 · Cited by 65
Lipotoxicity and cardiac dysfunction in mammals andDrosophila
Birse, R. T., & Bodmer, R. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.599830 · Cited by 49
“For example, insulin resistance in skeletal muscle is thought to initiate systemic insulin resistance, which induces increased FFA uptake and lipid accumulation in the heart, and ultimately leads to CVD (Figure 1)(Chow et al., 2010; DeFronzo and Tripathy, 2009; Bouzakri et al., 2005).”
InfluentialSugimoto, M., Shimizu, Y., Zhao, S., Ukon, N., Nishijima, K., Wakabayashi, M., Yoshioka, T., Higashino, K., Numata, Y., Okuda, T., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.04.019 · Cited by 48
Frias, F. D. T., de Mendonça, M., Martins, A. R., Gindro, A. F., Cogliati, B., Curi, R., & Rodrigues, A. C. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00076 · Cited by 46
“org June 2016 | Volume 7 | Article 76 muscle constitutes about 40% of total body weight and accounts for about 80% of the insulin-stimulated postprandial glucose utilization (2), this tissue is the major player in the development of IR and type 2 diabetes (3).”
Backgroundβ-Adrenergic Receptor and Insulin Resistance in the Heart
Mangmool, S., Denkaew, T., Parichatikanond, W., & Kurose, H. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.128 · Cited by 54
“In skeletal muscle , insulin resistance causes the reduction in both glucose trans - port and glycogen synthesis , which leads to inhibit glucose clearance ( DeFronzo and Tripathy , 2009 ) .”
Innate immune receptors in skeletal muscle metabolism
Pillon, N. J., & Krook, A. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.035 · Cited by 44
Andrich, D. E., Melbouci, L., Ou, Y., Auclair, N., Mercier, J., Grenier, J., Lira, F. S., Barreiro, L. B., Danialou, G., Comtois, A. S., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00372 · Cited by 45
“In fact, skeletal muscle insulin resistance is considered as the primary cause of type 2 diabetes (DeFronzo and Tripathy, 2009).”
BackgroundHDAC11 Inhibits Myoblast Differentiation through Repression of MyoD-Dependent Transcription
Byun, S. K., An, T. H., Son, M. J., Lee, D. S., Kang, H. S., Lee, E., Han, B., Kim, W. K., Bae, K., Oh, K., et al. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0116 · Cited by 47
Wang, T., Zheng, L. P., Zhao, T., Zhang, Q., Liu, Z., Liu, X., & Zhao, M. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104224 · Cited by 45
Tam, C. S., Redman, L. M., Greenway, F., LeBlanc, K. A., Haussmann, M. G., & Ravussin, E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1814 · Cited by 42
Gong, L., Zou, Z., Liu, L., Guo, S., & Xing, D. (2021) · Aging · doi:10.18632/aging.202760 · Cited by 47
Kiefer, L. S., Fabian, J., Rospleszcz, S., Lorbeer, R., Machann, J., Kraus, M. S., Roemer, F. W., Rathmann, W., Meisinger, C., Heier, M., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14413 · Cited by 47
“Thus, even minor changes in skeletal muscle composition regarding fat content and lipid distribution may be key factors contributing to the pathogenesis of insulin resistance and T2D.6,7 Intramuscular fat may be deposited in two distinct compartments, either as intramyocellular lipids (IMCLs) accumulated in the cytopl…”
BackgroundYassine, H. N., Solomon, V., Thakral, A., Sheikh‐Bahaei, N., Chui, H. C., Braskie, M. N., Schneider, L. S., & Talbot, K. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12474 · Cited by 43
Goldstein, M. R., & Mascitelli, L. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0368-x · Cited by 43
“It is noteworthy that skeletal muscle insulin resistance is thought to be a primary defect in diabetes [34], and even in moderate doses, statin therapy in real-life clinical practice is commonly associated with various muscular side effects [49•] that are not always evident in randomized clinical trials [50].”
BackgroundInfluentialSchisandra polysaccharide increased glucose consumption by up-regulating the expression of GLUT-4
Dun, J., Zhao, T., Feng, W., Mao, G., Zou, Y., Wang, W., Li, Q., Chen, Y., Wang, X.-T., Yang, L., et al. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.03.028 · Cited by 46
Ding, H., Heng, B., He, W., Shi, L., Lai, C., Xiao, L., Ren, H.-L., Mo, S., & Su, Z. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.028 · Cited by 43
A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects
Aguilar-Recarte, D., Barroso, E., Zhang, M., Rada, P., Pizarro‐Delgado, J., Peña, L., Palomer, X., Valverde, Á. M., Wahli, W., & Vázquez‐Carrera, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106578 · Cited by 51
“Skeletal muscle, which accounts for most of the insulin-stimulated glucose use [11], also takes up and accumulates metformin [2].”
BackgroundRoy, P. K., Islam, J., & Lalhlenmawia, H. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00352-7 · Cited by 56
“Skeletal muscle acts as a major organ participating in insulin stimulated glucose metabolism accounting 80% of total body glucose [182].”
BackgroundWitham, M. D., Granic, A., Pearson, E. R., Robinson, S. M., & Sayer, A. A. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01042-4 · Cited by 49
“…[39]. b. Insulin resistance and skeletal muscle glucose uptake Raised concentrations of insulin are found in individuals with insulin resistance, usually thought to be a response to impaired insulin-mediated skeletal muscle glucose uptake and hence higher circulating glucose concentrations [40].”
BackgroundObesity-related insulin resistance: implications for the surgical patient
Tewari, N., Awad, S., Macdonald, I. A., & Lobo, D. N. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.100 · Cited by 42
Ishii, S., Nagai, Y., Sada, Y., Fukuda, H., Nakamura, Y., Matsuba, R., Nakagawa, T., Kato, H., & Tanaka, Y. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3647 · Cited by 41
“The skeletal muscles handle about 40-45% of oral glucose intake, and account for up to 80-85% of insulinmediated glucose disposal [4, 5].”
BackgroundRai, A. K., Jaiswal, N., Maurya, C. K., Sharma, A., Ahmad, I., Ahmad, S., Gupta, A. P., Gayen, J. R., & Tamrakar, A. K. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.05.016 · Cited by 45
Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism
Williams, K., Ingerslev, L. R., Bork‐Jensen, J., Wohlwend, M., Hansen, A. N., Small, L., Ribel‐Madsen, R., Astrup, A. V., Pedersen, O. B., Auwerx, J. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16537-6 · Cited by 43
Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions
Анатольевич, П. И., & Pinelis, V. G. (2021) · Life · doi:10.3390/life11030262 · Cited by 47
Paquin, J., Lagacé, J.-C., Brochu, M., & Dionne, I. J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.656909 · Cited by 41
“SM accounts for up to 80% of whole-body glucose consumption under insulin-stimulated conditions (DeFronzo and Tripathy, 2009; Honka et al., 2018) and is thought to contribute to as much as 25% of basal metabolic rate (Dulloo et al., 2012).”
BackgroundSt‐Pierre, P., Genders, A. J., Keske, M. A., Richards, S. M., & Rattigan, S. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01235.x · Cited by 43
“Clear evidence positions defects in skeletal muscle insulin sensitivity as an early defect in insulin resistance, while the contribution of other tissues thereafter is undeniable [22].”
BackgroundEffects of Exercise Training on Regulation of Skeletal Muscle Glucose Metabolism in Elderly Men
Biensø, R. S., Olesen, J., Gliemann, L., Schmidt, J. F., Matzen, M. S., Wojtaszewski, J. F. P., Hellsten, Y., & Pilegaard, H. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glv012 · Cited by 41
“Such changes may pre-dispose to diseases like type 2 diabetes (4) and prevention of age-related dysfunctional glucose metabolism through physical activity is therefore important.”
BackgroundPersonalized molecular signatures of insulin resistance and type 2 diabetes
Kjærgaard, J., Stocks, B., Henderson, J., Freemantle, J. B., Rizo‐Roca, D., Puglia, M., Montoya, M. M., Andersson, D. P., Bäckdahl, J., Hogling, D. E., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.005 · Cited by 59
Permpoon, U., Moon, J., Kim, C. Y., & Nam, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157616 · Cited by 241
“Skeletal muscle is a major source of glucose storage in a stable complex branched form called glycogen [71].”
Role of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism
Li, M., Vienberg, S. G., Bezy, O., O’Neill, B. T., & Kahn, C. R. (2015) · Diabetes · doi:10.2337/db14-1891 · Cited by 40
“Insulin resistance in muscle is one of the characteristic features of type 2 diabetes and has been shown to exist in genetically susceptible individuals years prior to the onset of clinical diabetes (18).”
BackgroundIn vitro contraction protects against palmitate-induced insulin resistance in C2C12 myotubes
Nieuwoudt, S., Mulya, A., Fealy, C. E., Martelli, E. E., Dasarathy, S., Prasad, S. V. N., & Kirwan, J. P. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00123.2017 · Cited by 50
“Alternatively, this finding supports the notion of shared pools of recruitable glucose transporters (12).”
BackgroundResultThe emergence of protein arginine methyltransferases in skeletal muscle and metabolic disease
vanLieshout, T. L., & Ljubicic, V. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2019 · Cited by 40
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
Hoffman, N. J., Whitfield, J., Janzen, N. R., Belhaj, M. R., Galić, S., Murray‐Segal, L., Smiles, W. J., Ling, N. X. Y., Dite, T. A., Scott, J. W., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101048 · Cited by 43
“These findings may be due to AMPK b2’s predominant expression in skeletal muscle, a tissue responsible for the large majority (80e90%) of postprandial glucose disposal [38].”
BackgroundAl‐Ozairi, E., Alsaeed, D., Alroudhan, D., Voase, N., Hasan, A., Gill, J. M. R., Sattar, N. A., Welsh, P. I., Gray, C. M., Boonpor, J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa835 · Cited by 47
Joshi, D. M., Patel, J. B., & Bhatt, H. (2021) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-020-00274-3 · Cited by 42
“2014; DeFronzo et al.”
BackgroundInfluentialSphingosine 1-phosphate metabolism and insulin signaling
Wigger, D., Schumacher, F., Schneider‐Schaulies, S., & Kleuser, B. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109959 · Cited by 45
Sergi, D., Luscombe‐Marsh, N. D., Naumovski, N., Abeywardena, M. Y., & O’Callaghan, N. J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.663838 · Cited by 46
“Particularly, insulin resistance is the hallmark of T2DM and develops in the skeletal muscle decades before pancreatic β-cells become dysfunctional and overt hyperglycaemia develops (5).”
BackgroundMuratsu, J., Iwabayashi, M., Sanada, F., Taniyama, Y., Otsu, R., Rakugi, H., & Morishita, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-00199-4 · Cited by 41
Stocks, B., & Zierath, J. R. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab038 · Cited by 61
“As skeletal muscle is the predominant site for insulin-stimulated glucose disposal (8), insulin resistance in this tissue is critical to the development of type 2 diabetes (9, 10).”
BackgroundQueiroz, J. D. N., Macedo, R. C. O., dos Santos, G. C., Munhoz, S. V., Machado, C. L. F., de Menezes, R. L., Menzem, E. N., Moritz, C. E. J., Pinto, R. S., Tinsley, G. M., et al. (2023) · British Journal of Nutrition · doi:10.1017/s0007114522001581 · Cited by 39
Argyropoulou, D., Geladas, N. D., Nomikos, T., & Paschalis, V. (2022) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk7020048 · Cited by 47
The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications
Ouyang, S., Zhang, Q., Lou, L., Zhu, K., Li, Z., Liu, P., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871560 · Cited by 48
“A major and early characteristic of the pathogenesis of T2DM is insulin resistance in skeletal muscle (DeFronzo and Tripathy, 2009).”
BackgroundMetabolic Derangement by Arsenic: a Review of the Mechanisms
Bibha, K., Akhigbe, T. M., Hamed, M. A., & Akhigbe, R. E. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03828-4 · Cited by 44
“In an epidemiological study, it was shown that arsenic concentration was directly proportional to fasting blood glucose and HOMA-IR, but inversely associated with serum creatinine, a bio-marker of skeletal muscle mass [78] that is a predisposing factor for the development of DM [34].”
The association between sarcopenia and incident of depressive symptoms: a prospective cohort study
Li, Z., Liu, B., Tong, X., Ma, Y., Bao, T., Yue, J., & Wu, C. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04653-z · Cited by 44
“Low muscle mass may impair glucose homeostasis, and various studies have shown that there is a correlation between blood glucose homeostasis and depression [29].”
BackgroundJheng, H., Huang, S., Kuo, H., Hughes, M. W., & Tsai, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12863 · Cited by 39
Proteomic Analysis of Skeletal Muscle in Insulin-Resistant Mice: Response to 6-Week Aerobic Exercise
Yuan, H., Niu, Y., Liu, X., Yang, F., Niu, W., & Fu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053887 · Cited by 40
“As the predominant tissue for insulin-stimulated glucose and lipid disposal, skeletal muscle is crucial for the development of wholebody IR [3].”
BackgroundHan, X., Raun, S. H., Carlsson, M., Sjøberg, K. A., Henríquez‐Olguín, C., Ali, M. S., Lundsgaard, A., Fritzen, A. M., Møller, L. L. V., Li, Z., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154169 · Cited by 38
Campodonico-Burnett, W., Hetrick, B., Wesolowski, S. R., Schenk, S., Takahashi, D. L., Dean, T. A., Sullivan, E. L., Kievit, P., GANNON, M. A., Aagaard, K. M., et al. (2020) · Diabetes · doi:10.2337/db19-1218 · Cited by 42
Lee, J. H., Park, J. E., & Han, J.-S. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112973 · Cited by 40
Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs
Wang, L., Zhu, L., Meister, J., Bone, D. B. J., Pydi, S. P., Rossi, M., & Wess, J. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-121042 · Cited by 38
Kawano, R., Takahashi, F., Hashimoto, Y., Okamura, T., Miki, A., Kaji, A., Sakai, R., Kitagawa, N., Senmaru, T., Majima, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.049 · Cited by 39
Alshehade, S. A., Alshawsh, M. A., Murugaiyah, V., Asif, M., Alshehade, O., Almoustafa, H. A., & Zarzour, R. H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120732 · Cited by 44
Capsaicin, its clinical significance in patients with painful diabetic neuropathy
Dludla, P. V., Nkambule, B. B., Cirilli, I., Marcheggiani, F., Mabhida, S. E., Ziqubu, K., Ntamo, Y., Jack, B. U., Nyambuya, T. M., Hanser, S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113439 · Cited by 44
Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism
Guridi, M., Kupr, B., Romanino, K., Lin, S., Falcetta, D., Tintignac, L. A. J., & Rüegg, M. A. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0084-8 · Cited by 51
“For example, the skeletal muscle is the major site of glucose uptake in response to food intake and insulin and thus can contribute to type 2 diabetes [11].”
BackgroundSodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
Afşar, B., & Afşar, R. E. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.10.004 · Cited by 44
Russell‐Guzmán, J., Américo-Da-Silva, L., Cadagan, C., Maturana, M., Palomero, J., Estrada, M., Barrientos, G. C., Buvinic, S., Hidalgo, C., & Llanos, P. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.011 · Cited by 44
Endothelial Transcytosis of Insulin: Does It Contribute to Insulin Resistance?
Lee, W. L., & Klip, A. (2016) · Physiology · doi:10.1152/physiol.00010.2016 · Cited by 38
“(23) and is one of the earliest signs of Type 2”
BackgroundMullainadhan, V., Viswanathan, M. P., & Karundevi, B. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.015 · Cited by 40
High-Fat Diet-Induced Insulin Resistance in Single Skeletal Muscle Fibers is Fiber Type Selective
Pataky, M. W., Wang, H., Yu, C. S., Arias, E. B., Ploutz-Snyder, R. J., Zheng, X., & Cartee, G. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-12682-z · Cited by 42
“There are significant caveats in delineating fiber type differences based on conventional whole muscle analysis, including that: (1) no muscle is entirely composed of a single fiber type, (2) to our knowledge no rat muscle is primarily composed of type IIX fibers, (3) it is impossible to adequately evaluate fibers tha…”
Camargo, A., Jiménez-Lucena, R., Alcala-Diaz, J. F., Rangel-Zúñiga, O. A., García‐Carpintero, S., López-Moreno, J., Blanco-Rojo, R., Delgado‐Lista, J., Pérez‐Martínez, P., van Ommen, B., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.03.016 · Cited by 38
Ayeleso, T. B., Ramachela, K., & Mukwevho, E. (2018) · Molecules · doi:10.3390/molecules23082058 · Cited by 43
Ives, S. J., Zaleski, K. S., Slocum, C., Escudero, D., Sheridan, C., Legesse, S., Vidal, K., Lagalwar, S., & Reynolds, T. (2020) · Physiological Reports · doi:10.14814/phy2.14630 · Cited by 44
Deenadayalan, A., Subramanian, V., Paramasivan, V., Veeraraghavan, V. P., Rengasamy, G., Janaki, C. S., Rajagopal, P., & Jayaraman, S. (2021) · Molecules · doi:10.3390/molecules26247689 · Cited by 48
Huang, S., Xiang, C., & Song, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265221 · Cited by 42
Tian, Y., Liu, Y., Wang, S., Dong, Y., Su, T., Ma, H., & Zhang, Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.053 · Cited by 40
Son, J. S., Kim, H., Son, Y., Lee, H., Chae, S. A., Seong, J. K., & Song, W. (2017) · Muscle & Nerve · doi:10.1002/mus.25596 · Cited by 38
“Skeletal muscle has been considered the largest and most important organ in maintaining glucose metabolism,(1,2) especially for patients in a state of insulin resistance such as obesity and type 2 diabetes, who often have a problem with glucose uptake in skeletal muscle.(3) Disorders characterized by insulin resistanc…”
BackgroundPearson, T., Wattis, J. A. D., King, J. R., MacDonald, I. A., & Mazzatti, D. J. (2016) · Bulletin of Mathematical Biology · doi:10.1007/s11538-016-0181-1 · Cited by 37
“There is significant evidence that muscle is the first tissue to become insulin resistant; see, for instance, DeFronzo and Tripathy (2009).”
BackgroundKang, C., Park, M., & Lee, H. (2022) · Life · doi:10.3390/life12101630 · Cited by 41
Maurya, C. K., Arha, D., Rai, A. K., Kumar, S., Pandey, J., Avisetti, D. R., Kalivendi, S. V., Klip, A., & Tamrakar, A. K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.154 · Cited by 43
High-Intensity Interval Training for Improving Postprandial Hyperglycemia
Little, J. P., & Francois, M. E. (2014) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2014.963474 · Cited by 37
“Skeletal muscle insulin resistance is a primary defect in T2D (DeFronzo & Tripathy, 2009), and skeletal muscle is responsible for the majority of glucose disposal following ingestion of carbohydrates (DeFronzo, 2004).”
BackgroundAmouzou, C., Breuker, C., Fabre, O., Bourret, A., Lambert, K., Birot, O., Fédou, C., Dupuy, A., Cristol, J., Sutra, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154119 · Cited by 40
Effects of 17β-Estradiol and Androgen on Glucose Metabolism in Skeletal Muscle
Inada, A., FUJII, N. L., Inada, O., Higaki, Y., Furuichi, Y., & Nabeshima, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1261 · Cited by 38
Hydrogen Sulfide and Glucose Homeostasis: A Tale of Sweet and the Stink
Untereiner, A. A., & Wu, L. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7046 · Cited by 43
“…Glucose Uptake Skeletal muscle is one of the largest insulin-sensitive organs that accounts for roughly 85% of whole body glucose uptake, which plays a critical role in maintaining systemic glucose homeostasis as well as the interactive cross-talk be-tween the liver and adipose tissue (22, 30).”
Hanaoka, B. Y., Ithurburn, M. P., Rigsbee, C., Bridges, S. L., Moellering, D. R., Gower, B. A., & Bamman, M. M. (2018) · Arthritis Care & Research · doi:10.1002/acr.23775 · Cited by 41
“In humans, skeletal muscle is the principal site of glucose uptake in the postprandial state (36), and low appendicular lean mass has been shown to be significantly associated with insulin resistance in early RA (37).”
BackgroundThe PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance
Aguilar-Recarte, D., Palomer, X., Wahli, W., & Vázquez‐Carrera, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168555 · Cited by 44
Kim, A., Koo, J. H., Jin, X., Kim, W., Park, S., Park, S., Rhee, E. P., Choi, C. S., & Kim, S. G. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12777 · Cited by 44
“Metabolic dysfunction in skeletal muscle deregulates systemic glucose metabolism and induces hyperglycaemia.(2) To better understand the association between USP21 levels in skeletal muscle and glucose homeostasis, we assessed USP21 levels in the skeletal muscle of a type 2 diabetic patient.”
BackgroundAmérico-Da-Silva, L., Aguilera, J., Quinteros-Waltemath, O., Sánchez-Aguilera, P., Russell‐Guzmán, J., Cadagan, C., Meneses‐Valdés, R., Sánchez, G., Estrada, M., Jorquera, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910212 · Cited by 39
Geetha, T., Langlais, P. R., Luo, M., Mapes, R., Lefort, N., Chen, S., Mandarino, L. J., & Yi, Z. (2011) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-010-0051-2 · Cited by 42
“Defects in the insulin signaling pathway have been implicated in the development of insulin resistance and type 2 diabetes [14, 15].”
BackgroundJun, J. E., Lee, S.-E., Lee, Y., Kim, G., Jin, S., Jee, J. H., & Kim, J. H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac662 · Cited by 40
Increasing effect of Tangzhiqing formula on IRS-1-dependent PI3K/AKT signaling in muscle
Gao, J., Li, J., An, Y., Liu, X., Qian, Q., Wu, Y., Zhang, Y., & Wang, T. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-198 · Cited by 36
“In the early stages of type 2 diabetes, significant decreasing of glycogen synthesis in muscle is the distinguishing characteristic for the insulin resistance [1].”
BackgroundIncreasing Muscle Mass Improves Vascular Function in Obese ( db/db ) Mice
Qiu, S., MINTZ, J. D., Salet, C., Han, W., Giannis, A., Chen, F., Yu, Y., Su, Y., Fulton, D. J., & Stepp, D. W. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000854 · Cited by 37
“Skeletal muscle is the predominant site of insulin-mediated glucose uptake after meals.(42) Loss of muscle mass known as muscle atrophy occurs in catabolic disease, such as in diabetes mellitus patients.”
Background
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.